Cited by 126Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchCellular transport and secretion

The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.

The Role of SORL1 in Alzheimer’s Disease

Yin, Rui-Hua, Yu, Jin-Tai, Tan, Lan·2015·Molecular Neurobiology

DOI 10.1007/s12035-014-8742-5

Open this paper in CoChat — free account

Abstract

Genetic variation in SORL1 gene, also known as LR11, has been identified to associate with Alzheimer's disease (AD) through replicated genetic studies. As a type I transmembrane protein, SORL1 is composed of several distinct domains and belongs to both the low-density lipoprotein receptor (LDLR) family and the vacuolar protein sorting 10 (VPS10) domain receptor family. The level of SORL1 was found to be decreased in the AD brain which positively correlated with β-amyloid (Aβ) accumulation. Emerging data suggests that SORL1 contributes to AD through various pathways, including emerging as a central regulator of the trafficking and processing of amyloid precursor protein (APP), involvement in Aβ destruction, and interaction with ApoE and tau protein. Primarily, SORL1 interacts with distinct sets of cytosolic adaptors for anterograde and retrograde movement of APP between the trans-Golgi network (TGN) and early endosomes, thereby restricting the delivery of the precursor to endocytic compartments that favor amyloidogenic breakdown. In this article, we review recent epidemiological and genetical findings of SORL1 that related with AD and speculate the possible roles of SORL1 in the progression of this disease. Finally, given the potential contributions of SORL1 to AD pathogenesis, targeting SORL1 might present novel opportunities for AD therapy.

Integrity signals

Registry

Crossref · 10.1007/s12035-014-8742-5

Cites

61 of 61 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease
Rogaeva, E., Meng, Y., Lee, J. H., Gu, Y., Kawarai, T., Zou, F., Katayama, T., Baldwin, C. T., Cheng, R., Hasegawa, H., et al. (2007) · Nature Genetics · doi:10.1038/ng1943 · Cited by 1,167
Neuronal sorting protein-related receptor sorLA/LR11 regulates processing of the amyloid precursor protein
Andersen, O. M., Reiche, J., Schmidt, V., Gotthardt, M., Spoelgen, R., Behlke, J., von Arnim, C. A. F., Breiderhoff, T., Jansen, P., Wu, X., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503689102 · Cited by 655
The sorting receptor for yeast vacuolar carboxypeptidase Y is encoded by the VPS10 gene
Marcusson, E. G., Horazdovsky, B. F., Cereghino, J. L., Gharakhanian, E., & Emr, S. D. (1994) · Cell · doi:10.1016/0092-8674(94)90219-4 · Cited by 439
Depletion of GGA3 Stabilizes BACE and Enhances β-Secretase Activity
Tesco, G., Koh, Y. H., Kang, E. L., Cameron, A. N., Das, S., Sena-Esteves, M., Hiltunen, M., Yang, S.-H., Zhong, Z., Shen, Y., et al. (2007) · Neuron · doi:10.1016/j.neuron.2007.05.012 · Cited by 337
Loss of apolipoprotein E receptor LR11 in Alzheimer disease
Scherzer, C. R., Offe, K., Gearing, M., Rees, H. D., Fang, G., Heilman, C. J., Schaller, C., Bujo, H., Levey, A. I., & Lah, J. J. (2004) · Archives of Neurology · doi:10.1001/archneur.61.8.1200 · Cited by 316
Retromer Binds the FANSHY Sorting Motif in SorLA to Regulate Amyloid Precursor Protein Sorting and Processing
Fjorback, A. W., Seaman, M., Gustafsen, C., Mehmedbasic, A., Gokool, S., Wu, C., Militz, D., Schmidt, V., Madsen, P., Nyengaard, J. R., et al. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.2272-11.2012 · Cited by 253
Molecular Characterization of a Novel Human Hybrid-type Receptor That Binds the α2-Macroglobulin Receptor-associated Protein
Jacobsen, L., Madsen, P., Moestrup, S. K., Lund, A. H., Tommerup, N., Nykjær, A., Sottrup-Jensen, L., Gliemann, J., & Petersen, C. M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.49.31379 · Cited by 253
The Lipoprotein Receptor LR11 Regulates Amyloid β Production and Amyloid Precursor Protein Traffic in Endosomal Compartments
Offe, K., Dodson, S. E., Shoemaker, J. T., Fritz, J. J., Gearing, M., Levey, A. I., & Lah, J. J. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4946-05.2006 · Cited by 245
Identification of a novel conserved sorting motif required for retromer-mediated endosome-to-TGN retrieval
Seaman, M. N. J. (2007) · Journal of Cell Science · doi:10.1242/jcs.009654 · Cited by 244
Epidemiology and Etiology of Alzheimer’s disease: From Genetic to Non- Genetic Factors
Jiang, T., Yu, J., Tian, Y., & Tan, L. (2013) · Current Alzheimer Research · doi:10.2174/15672050113109990155 · Cited by 231
Self-citation
Elements of Neural Adhesion Molecules and a Yeast Vacuolar Protein Sorting Receptor Are Present in a Novel Mammalian Low Density Lipoprotein Receptor Family Member
Yamazaki, H., Bujo, H., Kusunoki, J., Seimiya, K., Kanaki, T., Morisaki, N., Schneider, W. J., & Saitō, Y. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.40.24761 · Cited by 205
SORL1 Is Genetically Associated with Late-Onset Alzheimer’s Disease in Japanese, Koreans and Caucasians
Miyashita, A., Koike, A., Jun, G., Wang, L.-S., Takahashi, S., Matsubara, E., Kawarabayashi, T., Shoji, M., Tomita, N., Arai, H., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058618 · Cited by 196
Sorting by the Cytoplasmic Domain of the Amyloid Precursor Protein Binding Receptor SorLA
Nielsen, M. S., Gustafsen, C., Madsen, P., Nyengaard, J. R., Hermey, G., Bakke, O., Mari, M., Schu, P., Pohlmann, R., Dennes, A., et al. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00815-07 · Cited by 184
SorLA/LR11 regulates processing of amyloid precursor protein via interaction with adaptors GGA and PACS-1
Schmidt, V., Sporbert, A., Rohe, M., Reimer, T., Rehm, A., Andersen, O. M., & Willnow, T. E. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705073200 · Cited by 181
An intronic ncRNA-dependent regulation of SORL1 expression affecting Aβ formation is upregulated in post-mortem Alzheimer's disease brain samples
Ciarlo, E., Massone, S., Penna, I., Nizzari, M., Gigoni, A., Dieci, G., Russo, C., Florio, T., Cancedda, R., & Pagano, A. (2012) · Disease Models & Mechanisms · doi:10.1242/dmm.009761 · Cited by 172
Lysosomal Sorting of Amyloid-β by the SORLA Receptor Is Impaired by a Familial Alzheimer’s Disease Mutation
Caglayan, S., Takagi-Niidome, S., Liao, F., Carlo, A.-S., Schmidt, V., Burgert, T., Kitago, Y., Füchtbauer, E.-M., Füchtbauer, A., Holtzman, D. M., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007747 · Cited by 166
Meta-analysis of the Association Between Variants in SORL1 and Alzheimer Disease
Reitz, C. (2011) · Archives of Neurology · doi:10.1001/archneurol.2010.346 · Cited by 162
The Association Between Genetic Variants in SORL1 and Alzheimer Disease in an Urban, Multiethnic, Community-Based Cohort
Lee, J. H., Cheng, R., Schupf, N., Manly, J. J., Lantigua, R., Stern, Y., Rogaeva, E. A., Wakutani, Y., Farrer, L. A., George‐Hyslop, P. S., et al. (2007) · Archives of Neurology · doi:10.1001/archneur.64.4.501 · Cited by 143
LR11/SorLA Expression Is Reduced in Sporadic Alzheimer Disease but not in Familial Alzheimer Disease
Dodson, S. E., Gearing, M., Lippa, C. F., Montine, T. J., Levey, A. I., & Lah, J. J. (2006) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/01.jnen.0000228205.19915.20 · Cited by 134
Brain-Derived Neurotrophic Factor Reduces Amyloidogenic Processing through Control of SORLA Gene Expression
Rohe, M., Synowitz, M., Glaß, R., Paul, S. M., Nykjær, A., & Willnow, T. E. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.3960-09.2009 · Cited by 126
Sorting receptor SORLA – a trafficking path to avoid Alzheimer disease
Willnow, T. E., & Andersen, O. M. (2013) · Journal of Cell Science · doi:10.1242/jcs.125393 · Cited by 121
Omega-3 Fatty Acid Docosahexaenoic Acid Increases SorLA/LR11, a Sorting Protein with Reduced Expression in Sporadic Alzheimer's Disease (AD): Relevance to AD Prevention
Ma, Q., Teter, B., Ubeda, O. J., Morihara, T., Dhoot, D. S., Nyby, M. D., Tuck, M. L., Frautschy, S. A., & Cole, G. M. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.3593-07.2007 · Cited by 115
Sortilin, SorCS1b, and SorLA Vps10p sorting receptors, are novel γ-secretase substrates
Nyborg, A. C., Ladd, T. B., Zwizinski, C. W., Lah, J. J., & Golde, T. E. (2006) · Molecular Neurodegeneration · doi:10.1186/1750-1326-1-3 · Cited by 102
Neuronal LR11/sorLA expression is reduced in mild cognitive impairment
Sager, K. L., Wuu, J., Leurgans, S. E., Rees, H. D., Gearing, M., Mufson, E. J., Levey, A. I., & Lah, J. J. (2007) · Annals of Neurology · doi:10.1002/ana.21190 · Cited by 96
LR11, a Mosaic LDL Receptor Family Member, Mediates the Uptake of ApoE-Rich Lipoproteins In Vitro
Taira, K., Bujo, H., Hirayama, S., Yamazaki, H., Kanaki, T., Takahashi, K., Ishii, I., Miida, T., Schneider, W. J., & Saitō, Y. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/hq0901.094500 · Cited by 96
A PACS‐1, GGA3 and CK2 complex regulates CI‐MPR trafficking
Scott, G. K., Hao, F., Thomas, L., Medigeshi, G. R., & Thomas, G. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601336 · Cited by 91
Effects of DHA- Rich n-3 Fatty Acid Supplementation on Gene Expression in Blood Mononuclear Leukocytes: The OmegAD Study
Vedin, I., Cederholm, T., Freund‐Levi, Y., Basun, H., Garlind, A., Irving, G. F., Eriksdotter, M., Wahlund, L., Dahlman, I. A., & Palmblad, J. E. W. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035425 · Cited by 90
Reduction of SorLA/LR11, a Sorting Protein Limiting β-Amyloid Production, in Alzheimer Disease Cerebrospinal Fluid
Ma, Q., Galasko, D. R., Ringman, J. M., Vinters, H. V., Edland, S. D., Pomakian, J., Ubeda, O. J., Rosario, E. R., Teter, B., Frautschy, S. A., et al. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.22 · Cited by 86
Association between SORL1 and Alzheimer's disease in a genome-wide study
Meng, Y., Lee, J. H., Cheng, R., George‐Hyslop, P. S., Mayeux, R. P., & Farrer, L. A. (2007) · Neuroreport · doi:10.1097/wnr.0b013e3282f13e7a · Cited by 86
SorLA Signaling by Regulated Intramembrane Proteolysis
Böhm, C., Seibel, N. M., Henkel, B., Steiner, H., Haass, C., & Hampe, W. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601660200 · Cited by 83
SORL1 variants and risk of late-onset Alzheimer’s disease
Li, Y., Rowland, C. M., Catanese, J. J., Morris, J. C., Lovestone, S., O’Donovan, M. C., Goate, A., Owen, M. J., Williams, J. H., & Grupe, A. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.09.001 · Cited by 79
Neuronal localization of a novel mosaic apolipoprotein E receptor, LR11, in rat and human brain
Motoi, Y., Aizawa, T., Haga, S., Nakamura, S., Namba, Y., & Ikeda, K. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01542-5 · Cited by 78
Quantitative modelling of amyloidogenic processing and its influence by SORLA in Alzheimer's disease
Schmidt, V., Baum, K., Lao, A., Rateitschak, K., Schmitz, Y., Teichmann, A., Wiesner, B., Petersen, C. M., Nykjaer, A., Wolf, J., et al. (2012) · The EMBO Journal · doi:10.1038/emboj.2011.352 · Cited by 75
Genetic loci associated with Alzheimer's disease and cerebrospinal fluid biomarkers in a Finnish case–control cohort
Elias-Sonnenschein, L. S., Helisalmi, S., Natunen, T., Hall, A., Paajanen, T., Herukka, S.-K., Laitinen, M., Remes, A. M., Koivisto, A. M., Mattila, K. M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059676 · Cited by 70
SORL1 haplotypes modulate risk of Alzheimer's disease in Chinese
Tan, E., Lee, J., Chen, C., Teo, Y. Y., Zhao, Y., & Lee, W. L. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.10.013 · Cited by 69
GGA1-mediated endocytic traffic of LR11/SorLA alters APP intracellular distribution and amyloid-β production
Herskowitz, J. H., Offe, K., Deshpande, A., Kahn, R., Levey, A. I., & Lah, J. J. (2012) · Molecular Biology of the Cell · doi:10.1091/mbc.e12-01-0014 · Cited by 62
SORL1 and SIRT1 mRNA expression and promoter methylation levels in aging and Alzheimer’s Disease
Furuya, T. K., Silva, P. N., Payão, S. L. M., Rasmussen, L. T., de Lábio, R. W., Bertolucci, P. H. F., Braga, I. L. S., Chen, E., Turecki, G., Mechawar, N., et al. (2012) · Neurochemistry International · doi:10.1016/j.neuint.2012.07.014 · Cited by 61
Association of distinct variants in SORL1 with cerebrovascular and neurodegenerative changes related to Alzheimer disease
Cuenco, K. T. (2008) · Archives of Neurology · doi:10.1001/archneur.65.12.1640 · Cited by 61
Expression of SORL1 and a novel SORL1 splice variant in normal and Alzheimers disease brain
Grear, K. E., Ling, I.-F., Simpson, J. F., Furman, J. L., Simmons, C. R., Peterson, S. L., Schmitt, F. A., Markesbery, W. R., Liu, Q., Crook, J. E., et al. (2009) · Molecular Neurodegeneration · doi:10.1186/1750-1326-4-46 · Cited by 56
Rho Kinase II Phosphorylation of the Lipoprotein Receptor LR11/SORLA Alters Amyloid-β Production
Herskowitz, J. H., Seyfried, N. T., Gearing, M., Kahn, R., Peng, J., Levey, A. I., & Lah, J. J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.167239 · Cited by 54
SORL1 is genetically associated with Alzheimer disease in a Japanese population
Kimura, R., Yamamoto, M. L., Morihara, T., Akatsu, H., Kudo, T., Kamino, K., & Takeda, M. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.06.014 · Cited by 50
Implication of Sex and SORL1 Variants in Italian Patients With Alzheimer Disease
Cellini, E., Tedde, A., Bagnoli, S., Pradella, S., Piacentini, S., Sorbi, S., & Nacmias, B. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.101 · Cited by 48
Association of SORL1 gene variants with Alzheimer's disease
Kölsch, H., Jessen, F., Wiltfang, J., Lewczuk, P., Dichgans, M., Teipel, S. J., Kornhuber, J., Frölich, L., Heuser, I., Peters, O., et al. (2009) · Brain Research · doi:10.1016/j.brainres.2009.01.044 · Cited by 47
Genetic Association between SORL1 Polymorphisms and Alzheimer’s Disease in a Japanese Population
Shibata, N., Ohnuma, T., Baba, H., Higashi, S., Nishioka, K., & Arai, H. (2008) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000149821 · Cited by 43
Impact of SORL1 Single Nucleotide Polymorphisms on Alzheimer’s Disease Cerebrospinal Fluid Markers
Alexopoulos, P., Guo, L., Kratzer, M., Westerteicher, C., Kurz, A., Perneczky, R., & Initiative, A. D. N. (2011) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000332017 · Cited by 42
Decreased expression of GGA3 Protein in Alzheimer's disease frontal cortex and increased co-distribution of BACE with the amyloid precursor protein
Santosa, C., Rasche, S., Barakat, A., Bellingham, S. A., Ho, M., Tan, J., Hill, A. F., Masters, C. L., McLean, C., & Evin, G. M. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.03.009 · Cited by 41
Influence of SORL1 gene variants: Association with CSF amyloid-β products in probable Alzheimer's disease
Kölsch, H., Jessen, F., Wiltfang, J., Lewczuk, P., Dichgans, M., Kornhuber, J., Frölich, L., Heuser, I., Peters, O., Schulz, J. B., et al. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.05.049 · Cited by 40
GGA Autoinhibition Revisited
Cramer, J. F., Gustafsen, C., Behrens, M. A., Oliveira, C. L. P., Pedersen, J. S., Madsen, P., Petersen, C. M., & Thirup, S. (2009) · Traffic · doi:10.1111/j.1600-0854.2009.01017.x · Cited by 40
A Study of the SORL1 Gene in Alzheimer's Disease and Cognitive Function
Liu, F., Ikram, M. A., Janssens, A. C. J. W., Schuur, M., de Koning, I., Isaacs, A. J., Struchalin, M. V., Uitterlinden, A. G., den Dunnen, J. T., Sleegers, K., et al. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1137 · Cited by 38
Amyloid-β-Related Genes SORL1 and ACE are Genetically Associated With Risk for Late-onset Alzheimer Disease in the Chinese Population
Ning, M., Yang, Y., Zhang, Z., Chen, Z., Zhao, T., Zhang, D., Zhou, D., Xu, J., Liu, Z., Wang, Y., et al. (2010) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e3181e6a575 · Cited by 38
Increased Levels of Soluble LR11 in Cerebrospinal Fluid of Patients with Alzheimer Disease
Ikeuchi, T., Hirayama, S., Miida, T., Fukamachi, I., Tokutake, T., Ebinuma, H., Takubo, K., Kaneko, H., Kasuga, K., Kakita, A., et al. (2010) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000315539 · Cited by 38
SORL1 is Genetically Associated with Neuropathologically Characterized Late-Onset Alzheimer's Disease
Wen, Y., Initiative, J. A. D. N., Miyashita, A., Kitamura, N., Tsukie, T., Saito, Y., Hatsuta, H., Murayama, S., Kakita, A., Takahashi, H., et al. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-122395 · Cited by 37
Inhibitors of Rho‐kinase modulate amyloid‐β (Aβ) secretion but lack selectivity for Aβ42
Leuchtenberger, S., Kummer, M. P., Kukar, T. L., Czirr, E., Teusch, N. E., Sagi, S. A., Berdeaux, R., Pietrzik, C. U., Ladd, T. B., Golde, T. E., et al. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03553.x · Cited by 30
An Updated Meta-Analysis of the Association between SORL1 Variants and the Risk for Sporadic Alzheimer's Disease
Jin, C., Liu, X., Zhang, F., Wu, Y., Yuan, J., Zhu, J., Zhang, F., Wang, G., & Cheng, Z. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130533 · Cited by 28
SORL1 genetic variants and cerebrospinal fluid biomarkers of Alzheimer’s disease
Guo, L., Westerteicher, C., Wang, X., Kratzer, M., Tsolakidou, A. F., Jiang, M., Grimmer, T., Laws, S. M., Alexopoulos, P., Bujo, H., et al. (2012) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-012-0295-x · Cited by 28
Single-nucleotide polymorphisms of GSK3B, GAB2 and SORL1 in late-onset Alzheimer's disease: interactions with the APOE genotype
Izzo, G., Forlenza, O. V., dos Santos, B., Bertolucci, P. H. F., Ojopi, E. P. B., Gattaz, W. F., & Kerr, D. S. (2013) · Clinics · doi:10.6061/clinics/2013(02)rc01 · Cited by 26
Protein kinase C and rho activated coiled coil protein kinase 2 (ROCK2) modulate Alzheimer's APP metabolism and phosphorylation of the Vps10-domain protein, SorL1
Lane, R. F., Small, S. A., Gatson, J. W., Ehrlich, M. E., & Gandy, S. (2010) · Molecular Neurodegeneration · doi:10.1186/1750-1326-5-62 · Cited by 21
β‐Site amyloid precursor protein–cleaving enzyme 1 activity is related to cerebrospinal fluid concentrations of sortilin‐related receptor with A‐type repeats, soluble amyloid precursor protein, and tau
Tsolakidou, A. F., Alexopoulos, P., Guo, L., Grimmer, T., Westerteicher, C., Kratzer, M., Jiang, M., Bujo, H., Roselli, F., Leante, M. R., et al. (2012) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2012.01.015 · Cited by 19
SorLA Deficiency Dissects Amyloid Pathology from Tau and Cholinergic Neurodegeneration in a Mouse Model of Alzheimer's Disease
Capsoni, S., Carlo, A.-S., Vignone, D., Amato, G., Criscuolo, C., Willnow, T. E., & Cattaneo, A. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-121399 · Cited by 17
Association between the SORL1 rs2070045 polymorphism and late-onset Alzheimer's disease: Interaction with the ApoE genotype in the Chinese Han population
Xue, X., Zhang, M., Lin, Y., Xu, E., & Jia, J. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.11.042 · Cited by 15
Effects of SORL1 Gene on Alzheimer's Disease. Focus on Gender, Neuropsychiatric Symptoms and Pro-Inflammatory Cytokines
Olgiati, P., Politis, A. M., Albani, D., Rodilossi, S., Polito, L., Zisaki, A., Piperi, C., Liappas, I., Stamouli, E., Mailis, A., et al. (2013) · Current Alzheimer Research · doi:10.2174/1567205011310020005 · Cited by 13

Sorted by citations

Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease
Guo, T., Zhang, D., Zeng, Y., Huang, T. Y., Xu, H., & Zhao, Y. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00391-7 · Cited by 994
Alzheimer’s Disease: An Updated Overview of Its Genetics
Andrade-Guerrero, J., Santiago-Balmaseda, A., Jeronimo-Aguilar, P., Vargas-Rodríguez, I., Cadena-Suárez, A. R., Sánchez-Garibay, C., Pozo-Molina, G., Méndez-Catalá, C. F., Cardenas-Aguayo, M.-D.-C., Diaz-Cintra, S., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043754 · Cited by 336
The biological pathways of Alzheimer disease: a review
Calabrò, M., Rinaldi, C., Santoro, G., & Crisafulli, C. (2020) · AIMS neuroscience · doi:10.3934/neuroscience.2021005 · Cited by 287
Questions concerning the role of amyloid-β in the definition, aetiology and diagnosis of Alzheimer’s disease
Morris, G. P., Clark, I. A., & Vissel, B. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1918-8 · Cited by 212
Noncoding RNAs in Alzheimer's disease
Idda, M. L., Munk, R. B., Abdelmohsen, K., & Gorospe, M. (2018) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1463 · Cited by 211

See all 126

Authors: Yin, R.-H., Yu, J.-T., & Tan, L.
Affiliations: Qingdao University (CN)
Corresponding author: Tan, Lan
ORCID: Yu, Jin-Tai
Tan, Lan
Venue: Molecular Neurobiology
Publisher: Springer Science and Business Media LLC
Published: 2014-05-16
Volume: 51
Issue: 3
Pages: 909-918
ISSN: 0893-7648 (ISSN-L)
1559-1182
DOI: 10.1007/s12035-014-8742-5
OpenAlex: W2064885915
Cited by: 126
References: 61
Citations by year: 2026: 13 · 2025: 9 · 2024: 17 · 2023: 15 · 2022: 8 · 2021: 13 · 2020: 15 · 2019: 9 · 2018: 8 · 2017: 4 · 2016: 7 · 2015: 4 · 2014: 4
FWCI: 0.74
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Molecular Neurobiology (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular transport and secretion
Keywords: SORL1, Alzheimer's disease, genetic association, amyloid precursor protein, amyloid-beta, APP trafficking, apolipoprotein E, tau protein, trans-Golgi network, early endosomes, amyloidogenic processing, disease progression, therapeutic target
MeSH terms: Alzheimer Disease, Animals, Humans, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, LDL-Receptor Related Proteins, Membrane Transport Proteins, Amyloid Precursor Protein Secretases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The Role of SORL1 in Alzheimer’s Disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks